Abstract
Background:Interstitial lung disease (ILD) is the second leading cause of mortality in patients with rheumatoid arthritis (RA) (1). However, is frequently underrecognized as presents a highly variable clinical course, ranging...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have